Font Size: a A A
Keyword [Parkinson'S disease]
Result: 61 - 80 | Page: 4 of 10
61. Selective Activation Of Group Ⅱ Or Ⅲ MGluRs Expressed In Astrocytes Exerted Neuroprotective Effects On Primary Cultured Midbrain Neurons
62. Relationships Between ATP Sensitive Potassium Channels And Parkinson's Disease
63. The Study Of Functional Changes In Cortex Of Frontal And Parietal Lobes In Parkinson's Disease And Its Mechanism
64. Proinflammatory Cytokine Expression In Fetal Rat Brain And Dopaminergic Neuron Loss In Postnatal Rat Brain After Maternal Lipopolysacchrade Administration
65. The Rat's Neural Stem Cells Derived From Bone Marrow Stromal Cells Definited Induced And Differentiaed Into Dopaminergic Neuron
66. Paraquat Induced Nigrostriatal Dopaminergic Degeneration And Neuroprotective Effects Of Polygonum Multiflorum
67. Therapeutic Study Of Bone Marrow Mesenchymal Stem Cells On Rat Models Of Parkinson's Disease
68. Therapeutic Study Effect Of Co-graft Of Schwann Cells With Neural Stem Cells On Animal Model With Parkinson's Disease
69. Experimental Study On Mechanism Of PD Ⅰ Treating For Parkinson's Disease
70. Dynamic Proteomic Studies Of The Model Of Parkinson's Disease Induced By Proteasome Inhibitor In PC12 Cells
71. Proteomic Study Of Oxidative Modification In PC12 Cell Model Of PD Treated With PSI
72. Proteomic Studies On The Mechanism Of Cytotoxicity Induced By Rotenone In PC12 Cells
73. Morphogenetic And Proteomic Studies Of Inclusions In Dopaminergic PC12 Cells Treated With Proteasome Inhibitor PSI
74. Proteomic Research Of Protein Nitration, Phosphorylation And Glycosylation In PC12 Cells Treated With PSI
75. Association Analysis Of The Parkin Gene And Mutation Screening In Sporadic Parkinson's Disease Patients And Family Parkinsonism Patients
76. Proteomic Studies Of Proteasomal Inhibitor PSI-treated PC12 Cells
77. Proteomic Studies Of PD Model Induced By MPP~+ In PC12 Cells
78. Production Of Blood-brain-barrier-penetrating PTD-BDNF And Its Biological Effect
79. Neuroprotective Mechanisms Of Exercise In Mice Parkinsonism
80. Construction Of α-synuclein Transgenic Cell Model And Study Of The Cytoprotective Action Of The Three Compounds
  <<First  <Prev  Next>  Last>>  Jump to